Pacira Biosciences, Inc. (PCRX)
25.20
+0.44
(+1.78%)
USD |
NASDAQ |
Oct 07, 16:00
25.20
0.00 (0.00%)
After-Hours: 16:05
Pacira Biosciences Profit Margin (Quarterly) : 2.42% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.42% |
| March 31, 2026 | 1.64% |
| December 31, 2025 | 0.83% |
| September 30, 2025 | 3.03% |
| June 30, 2025 | -2.68% |
| March 31, 2025 | 2.85% |
| December 31, 2024 | 8.57% |
| September 30, 2024 | -85.11% |
| June 30, 2024 | 10.61% |
| March 31, 2024 | 5.37% |
| December 31, 2023 | 13.72% |
| September 30, 2023 | 6.62% |
| June 30, 2023 | 15.20% |
| March 31, 2023 | -12.18% |
| December 31, 2022 | -5.87% |
| September 30, 2022 | -0.41% |
| June 30, 2022 | 11.73% |
| March 31, 2022 | 4.32% |
| December 31, 2021 | -3.22% |
| September 30, 2021 | 13.83% |
| June 30, 2021 | 14.07% |
| March 31, 2021 | 8.71% |
| December 31, 2020 | 11.08% |
| September 30, 2020 | |
| June 30, 2020 | -9.63% |
| Date | Value |
|---|---|
| March 31, 2020 | 7.72% |
| December 31, 2019 | -3.99% |
| September 30, 2019 | -5.81% |
| June 30, 2019 | 2.66% |
| March 31, 2019 | -3.03% |
| December 31, 2018 | 8.71% |
| September 30, 2018 | -0.77% |
| June 30, 2018 | 3.05% |
| March 31, 2018 | -14.32% |
| December 31, 2017 | 5.81% |
| September 30, 2017 | -11.28% |
| June 30, 2017 | -27.83% |
| March 31, 2017 | -28.67% |
| December 31, 2016 | -5.45% |
| September 30, 2016 | -32.42% |
| June 30, 2016 | -11.43% |
| March 31, 2016 | -5.89% |
| December 31, 2015 | -3.60% |
| September 30, 2015 | 4.96% |
| June 30, 2015 | 0.01% |
| March 31, 2015 | 2.16% |
| December 31, 2014 | 9.39% |
| September 30, 2014 | -5.77% |
| June 30, 2014 | -10.68% |
| March 31, 2014 | -31.30% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Liquidia Corp. | 43.52% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.09% |
| Return on Assets | 1.12% |
| Return on Invested Capital | 1.26% |
| Gross Profit Margin (Quarterly) | 69.60% |
| Operating Margin (Quarterly) | 6.16% |
| Return on Net Operating Assets | 1.74% |